To promote the innovative development of the big health industry, Mayor Gong Zheng meets with the predecessor of Global CEO of British company Helion, Global CEO
Shanghai Mayor Gong Zheng met with the Global CEO of British company Herrion, led by Mai Borui, today.
Shanghai's economy is showing a sustained trend of stabilization and improvement, and it remains one of the most favored investment destinations for foreign investors and the preferred location for multinational corporations to layout their global industrial chains. Biomedical industry is one of the three key leading industries in Shanghai, and we are accelerating the construction of a globally influential innovation highland and world-class biopharmaceutical industry cluster. We hope that Helion Company can leverage its strengths and contributions, increase its forward-looking layout in advanced medical technology, strengthen cooperation with local research institutes and enterprises, and promote innovative development in the big health industry. Welcome the company to actively participate in the 6th CIIE, introduce more new products, technologies, and services to China, and settle in Shanghai. Shanghai will continue to create a first-class business environment and assist various enterprises in growing and strengthening in Shanghai.
Mai Borui said that China has been and will continue to be an important market for Helion. We view Shanghai as the cornerstone and hub of China's business growth, and also as a strong partner in the company's global layout. We will strengthen our headquarters in China to better support the company's business development in China. Helion has participated in five consecutive CIIE sessions and will continue to participate this year.
Helion is a leader in the field of consumer health products. Its predecessor was GlaxoSmithKline Consumer Health Products, which was spun off and listed independently in July 2022. Its headquarters are located in London and its China headquarters are located in Shanghai.